Data / Form D filings / ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc.: Form D filings
ThermoGenesis Holdings, Inc., a biotechnology company in Rancho Cordova, CA, filed 5 Form D notices with the SEC between 2015 and 2023. The latest, on March 28, 2023, reports $3 million sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2711 CITRUS ROAD, Rancho Cordova, CA, 95742
- Phone
- (916) 858-5100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 811212
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | New notice | $3,000,001 | $3,000,001 | 1 | Mar 20, 2023 | sec.gov | |
| Feb 14, 2019 | New notice | $800,000 | $800,000 | 1 | Jan 29, 2019 | sec.gov | |
| Apr 12, 2018 | New notice | $816,912 | $816,912 | 5 | Mar 26, 2018 | sec.gov | |
| Feb 26, 2016 | New notice | $15,000,000 | $15,000,000 | 2 | Feb 13, 2016 | sec.gov | |
| Sep 15, 2015 | New notice | $15,000,000 | $15,000,000 | 2 | Aug 31, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Xiaochun Xu | Executive Officer, Director | |
| Haihong Zhu | Executive Officer, Director | |
| Joseph Thomis | Director | |
| Russell Medford | Director | |
| Vivian Liu | Director | |
| Jeffery Cauble | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 27, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ThermoGenesis Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.